Bispecific Antibodies for Cancer Market – Dual-Targeting Immunotherapy Expanding Treatment Options
Market Overview Cancer immunotherapy continues to advance through molecules capable of engaging two distinct targets simultaneously. The Bispecific Antibodies For Cancer Market is growing as oncology developers pursue therapies that simultaneously bind tumor antigens and immune effector cells, enhancing the immune system's ability to target malignant cells directly. Hematology-oncology centers...
0 Commentarios 0 Acciones 45 Views 0 Vista previa